BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7691927)

  • 1. M4 and M9 autoantigens in primary biliary cirrhosis--a negative study.
    Palmer JM; Yeaman SJ; Bassendine MF; James OF
    J Hepatol; 1993 Jun; 18(2):251-4. PubMed ID: 7691927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?
    Davis PA; Leung P; Manns M; Kaplan M; Munoz SJ; Gorin FA; Dickson ER; Krawitt E; Coppel R; Gershwin ME
    Hepatology; 1992 Nov; 16(5):1128-36. PubMed ID: 1330864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space.
    Klein R; Berg PA
    Clin Exp Immunol; 1991 Jun; 84(3):445-8. PubMed ID: 2044223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase.
    Klein R; Berg PA
    Clin Exp Immunol; 1990 Jul; 81(1):65-71. PubMed ID: 1696184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9.
    Berg PA; Klein R
    Klin Wochenschr; 1986 Oct; 64(19):897-909. PubMed ID: 3537495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis.
    Klein R; Berg PA
    Clin Exp Immunol; 1988 Oct; 74(1):68-74. PubMed ID: 2464450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
    Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited.
    Berg PA; Klein R
    Liver; 1995 Dec; 15(6):281-92. PubMed ID: 8609807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis.
    Oertelt S; Rieger R; Selmi C; Invernizzi P; Ansari AA; Coppel RL; Podda M; Leung PS; Gershwin ME
    Hepatology; 2007 Mar; 45(3):659-65. PubMed ID: 17326160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimitochondrial and antinuclear antibodies in primary biliary cirrhosis: an update in relation to their biochemical characterization and clinical significance.
    Brenard R; Geubel AP
    Acta Clin Belg; 1991; 46(5):305-12. PubMed ID: 1721757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance.
    Berg PA; Klein R
    Dig Dis; 1992; 10(2):85-101. PubMed ID: 1530697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens.
    Frazer IH; Mackay IR; Jordan TW; Whittingham S; Marzuki S
    J Immunol; 1985 Sep; 135(3):1739-45. PubMed ID: 2410503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantigens in primary biliary cirrhosis.
    Jones DE
    J Clin Pathol; 2000 Nov; 53(11):813-21. PubMed ID: 11127262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of primary biliary cirrhosis (PBC) specific mitochondrial determinants by immunoblotting.
    Manns M; Gerken G; Trautwein C; Meuer M; Porally T; Dienes HP; Meyer zum Büschenfelde KH
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(2):59-66. PubMed ID: 2441951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients.
    Berg CP; Stein GM; Klein R; Pascu M; Berg T; Kammer W; Priemer M; Nordheim A; Schulze-Osthoff K; Gregor M; Wesselborg S; Berg PA
    Liver Int; 2006 Sep; 26(7):846-55. PubMed ID: 16911468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
    Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME
    Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimitochondrial antibodies in primary biliary cirrhosis.
    Leung PS; Coppel RL; Ansari A; Munoz S; Gershwin ME
    Semin Liver Dis; 1997 Feb; 17(1):61-9. PubMed ID: 9089911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis.
    Klein R; Klöppel G; Fischer R; Fintelmann V; Müting D; Berg PA
    J Hepatol; 1988 Jun; 6(3):299-306. PubMed ID: 3392380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies.
    Bunn CC; McMorrow M
    Clin Exp Immunol; 1995 Oct; 102(1):131-6. PubMed ID: 7554379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.